IL148770A0 - The gene prv-1 and antibodies and pharmaceutical compositions for treating polycythemia vera - Google Patents
The gene prv-1 and antibodies and pharmaceutical compositions for treating polycythemia veraInfo
- Publication number
- IL148770A0 IL148770A0 IL14877000A IL14877000A IL148770A0 IL 148770 A0 IL148770 A0 IL 148770A0 IL 14877000 A IL14877000 A IL 14877000A IL 14877000 A IL14877000 A IL 14877000A IL 148770 A0 IL148770 A0 IL 148770A0
- Authority
- IL
- Israel
- Prior art keywords
- prv
- antibodies
- gene
- pharmaceutical compositions
- polycythemia vera
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19947010A DE19947010A1 (de) | 1999-09-30 | 1999-09-30 | Das Gen PRV-1 und dessen Verwendung |
PCT/EP2000/009594 WO2001023554A1 (de) | 1999-09-30 | 2000-09-29 | Das gen prv-1 und dessen verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
IL148770A0 true IL148770A0 (en) | 2002-09-12 |
Family
ID=7923937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14877000A IL148770A0 (en) | 1999-09-30 | 2000-09-29 | The gene prv-1 and antibodies and pharmaceutical compositions for treating polycythemia vera |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1220920A1 (sk) |
JP (1) | JP2003510077A (sk) |
KR (1) | KR20020047191A (sk) |
CN (1) | CN1377408A (sk) |
AU (1) | AU1132401A (sk) |
BG (1) | BG106554A (sk) |
BR (1) | BR0014444A (sk) |
CA (1) | CA2387702A1 (sk) |
CZ (1) | CZ20021094A3 (sk) |
DE (1) | DE19947010A1 (sk) |
EA (1) | EA200200286A1 (sk) |
EE (1) | EE200200168A (sk) |
HR (1) | HRP20020269A2 (sk) |
HU (1) | HUP0203080A2 (sk) |
IL (1) | IL148770A0 (sk) |
MX (1) | MXPA02002800A (sk) |
NO (1) | NO20021498L (sk) |
PL (1) | PL354184A1 (sk) |
SK (1) | SK4262002A3 (sk) |
WO (1) | WO2001023554A1 (sk) |
ZA (1) | ZA200202379B (sk) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL158599A0 (en) * | 2003-10-26 | 2004-05-12 | Yeda Res & Dev | Methods of modulating hematopoiesis |
MX2014014166A (es) | 2012-05-21 | 2015-03-03 | Genentech Inc | Metodos para mejorar la seguridad del transporte de la barrera hematoencefalica. |
EP3638774B1 (en) * | 2017-06-14 | 2024-08-07 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999063088A2 (en) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Membrane-bound proteins and nucleic acids encoding the same |
AU746956B2 (en) * | 1997-05-06 | 2002-05-09 | Zymogenetics Inc. | Novel tumor antigens |
DE19849044A1 (de) * | 1998-10-23 | 2000-04-27 | Univ Ludwigs Albert | Das Gen PRV-1 und dessen Verwendung |
KR100468978B1 (ko) * | 1998-12-16 | 2005-02-02 | 제넨테크, 인크. | 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산 |
-
1999
- 1999-09-30 DE DE19947010A patent/DE19947010A1/de not_active Withdrawn
-
2000
- 2000-09-29 KR KR1020027004095A patent/KR20020047191A/ko not_active Application Discontinuation
- 2000-09-29 CA CA002387702A patent/CA2387702A1/en not_active Abandoned
- 2000-09-29 EP EP00972665A patent/EP1220920A1/de not_active Withdrawn
- 2000-09-29 MX MXPA02002800A patent/MXPA02002800A/es unknown
- 2000-09-29 AU AU11324/01A patent/AU1132401A/en not_active Abandoned
- 2000-09-29 HU HU0203080A patent/HUP0203080A2/hu unknown
- 2000-09-29 SK SK426-2002A patent/SK4262002A3/sk unknown
- 2000-09-29 IL IL14877000A patent/IL148770A0/xx unknown
- 2000-09-29 CN CN00813580A patent/CN1377408A/zh active Pending
- 2000-09-29 EE EEP200200168A patent/EE200200168A/xx unknown
- 2000-09-29 WO PCT/EP2000/009594 patent/WO2001023554A1/de not_active Application Discontinuation
- 2000-09-29 JP JP2001526936A patent/JP2003510077A/ja active Pending
- 2000-09-29 PL PL00354184A patent/PL354184A1/xx not_active IP Right Cessation
- 2000-09-29 BR BR0014444-4A patent/BR0014444A/pt not_active Application Discontinuation
- 2000-09-29 EA EA200200286A patent/EA200200286A1/ru unknown
- 2000-09-29 CZ CZ20021094A patent/CZ20021094A3/cs unknown
-
2002
- 2002-03-25 ZA ZA200202379A patent/ZA200202379B/en unknown
- 2002-03-26 NO NO20021498A patent/NO20021498L/no not_active Application Discontinuation
- 2002-03-27 BG BG106554A patent/BG106554A/bg unknown
- 2002-03-28 HR HR20020269A patent/HRP20020269A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1220920A1 (de) | 2002-07-10 |
AU1132401A (en) | 2001-04-30 |
PL354184A1 (en) | 2003-12-29 |
NO20021498D0 (no) | 2002-03-26 |
WO2001023554A1 (de) | 2001-04-05 |
SK4262002A3 (en) | 2002-09-10 |
EA200200286A1 (ru) | 2002-12-26 |
NO20021498L (no) | 2002-05-23 |
BR0014444A (pt) | 2002-06-11 |
HUP0203080A2 (hu) | 2002-12-28 |
ZA200202379B (en) | 2003-10-29 |
JP2003510077A (ja) | 2003-03-18 |
HRP20020269A2 (en) | 2003-06-30 |
CZ20021094A3 (cs) | 2002-06-12 |
BG106554A (bg) | 2003-01-31 |
EE200200168A (et) | 2003-04-15 |
DE19947010A1 (de) | 2001-04-05 |
KR20020047191A (ko) | 2002-06-21 |
CA2387702A1 (en) | 2001-04-05 |
MXPA02002800A (es) | 2002-07-22 |
CN1377408A (zh) | 2002-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL193615A0 (en) | New azaindoles for inhibiting protein kinases and pharmaceutical composition comprising the same | |
IL162183A0 (en) | Polymer-lipid delivery vehicles and methods for the preparation thereof | |
IL150224A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
IL150223A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
HUP0201376A2 (en) | Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds | |
IL138990A0 (en) | Matrices for drug delivery and methods for making and using the same | |
HK1045650B (zh) | 藥物組合物 | |
HK1080724A1 (en) | Stabilized pharmaceutical composition in lyophilized form | |
HUP0104795A3 (en) | Azabicycloalkanes as ccr5 modulators, pharmaceutical compositions comprising thereof and their use | |
PT1239829E (pt) | Dispositivos para administração de fármacos com propriedades antiprogestativas | |
IL138280A0 (en) | 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
HUP0203325A3 (en) | Bicyclic amino acids, pharmaceutical compositions containing them and their use | |
HUP0104762A3 (en) | Pharmaceutical moxifloxacin compositions and process for their preparation | |
AP2000002010A0 (en) | Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof | |
AU5326100A (en) | Pharmaceutical compositions and methods for use | |
EP1180006A4 (en) | COMPOSITIONS AND METHODS FOR PREPARING SUCH COMPOSITIONS FROM LEPIDIA | |
PL352159A1 (en) | Pharmaceutical compositions containing antibody against the fas | |
IL138888A0 (en) | Pharmaceutical composition and combination preparation for immunosuppressive therapy | |
IL156262A0 (en) | Anti-cd28 antibodies having no mitogenic activity and pharmaceutical compositions containing the same | |
IL145520A0 (en) | Flame-retarding composition and process for the preparation thereof | |
HUP0101256A3 (en) | Pharmaceutical composition having antitumor activity and process for the preparation thereof | |
AU4312101A (en) | Secure delivery receptacle and method for using the same | |
IL148770A0 (en) | The gene prv-1 and antibodies and pharmaceutical compositions for treating polycythemia vera | |
HUP0203310A3 (en) | Stable pharmaceutical compositions comprising benzimidazol and method for the production thereof | |
EP1173192A4 (en) | METHOD AND COMPOSITIONS FOR TARGETED MEDICINE ADMINISTRATION |